Correlation between serum magnesium levels and diabetic retinopathy in type 2 diabetes mellitus
Keywords:Diabetes mellitus, Diabetes retinopathy, Magnesium, Serum
Background: In this study, an attempt has been made to find the correlation between Diabetic Retinopathy (DR) and serum magnesium in type 2 Diabetic Mellitus (DM) cases.
Methods: Study was conducted in the department of General Medicine, GSL Medical College. Study protocol was approved by institutional ethical committee. All the non-critically ill type 2 DM individuals of all ages attended the outpatient services were included in the study. The reference range of Magnesium was taken as 1.7-2.4 mg/dL. Patients with low and normal Magnesium levels were categorized as cases and controls respectively. Statistical analysis was performed using SPSS software 21, Chi square test was used to compare the different qualitative variables; p<0.05 was considered as statistically significant.
Results: A total of 163 individuals were included in the study, the mean age was 55.72 years, ranged between 39 to 75 years; male female ratio was 1.12. DR was diagnosed in 54% cases and low magnesium levels were detected in 40% cases; the difference was statistically not significant (p>0.05).
Conclusions: Estimation of glycaemic levels and serum magnesium can help us predict the onset and progression of DR.
Corrêa ZM, Freitas AM, Marcon IM. Risk factors related to the severity of diabetic retinopathy. Arquivos Brasileiros de Oftalmologia. 2003;66(6):739-43.
Chiarelli F, Mohn A, Tumini S, Trotta D, Verrotti A. Screening for vascular complications in children and adolescents with type 1 diabetes mellitus. Hormone Res Paediatr. 2002;57:113-6.
Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC ophthalmol. 2004;4(1):9.
Kareem I, Jaweed SA, Bardapurkar JS, Patil VP. Study of magnesium, glycosylated hemoglobin and lipid profile in diabetic retinopathy. Ind J Clini biochem. 2004;19(2):124.
Wälti MK, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss Med Weekly. 2003;133(1920).
Vijan S, Stevens DL, Herman WH, Funnell MM, Standiford CJ. Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus: putting evidence into practice. J Gen Int Med. 1997;12(9):567-80.
Jameson JL, Kasper D, Hauser S, Longo D. Harrisons principles of internal medicine. 19th ed. New York. McGraw-Hill Education. 2017.
Diabetic retinopathy among self-reported diabetics in southern India: a population-based assessment, 2014. Available at: http://bjo.bmj.com/content/86/9/1014. Accessed 22 January 2019.
Diabetic retinopathy: An Indian perspective 2009. Available at: http://medind.nic.in/iby/t07/i3/ibyt07i3p297.pdf. Accessed 4 May 2019.
Raman R, Ganesan S, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diab Res Care. 2014;2(1):e000005.
Parving HH, Mogensen CE, Thomas MC, Brenner BM, Cooper ME. Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study. Qjm. 2005;98(2):119-26.
Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Bri J Anaesth. 1999;83(2):302-20.
Turecky L, Kupcova V, Szantova M, Uhlikova E, Viktorinova A, Czirfusz A. Serum magnesium levels in patients with alcoholic and non-alcoholic fatty liver. Bratislavské Lekárske Listy. 2006;107(3):58.
Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clini J Am Soci Nephrol. 2007;2(2):366-73.